A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.
By Dana Karni, Kareem Khadder, Ivana Kottasová, Eugenia Yosef and Jeremy Diamond, CNN (CNN) — Israel is preparing to receive on Saturday four female soldiers held hostage by Hamas, an Israeli official ...